| Titre : | Addiction, Vol.116, n°6 - June 2021 |
| Type de document : | Bulletin : Périodique |
| Paru le : | 01/06/2021 |
| Année de publication : | 2021 |
| Format : | 1299-1615 |
| Langues: | Anglais |
| Note de contenu : |
CONTENTS:
- Is substance use changing because of the COVID-19 pandemic? Conceptual and methodological considerations to delineating the impact of the COVID-19 pandemic on substance use and disorder [Editorial]. Jager J., Keyes K.M., p. 1301-1303. - The dawn of a new synthetic opioid era: the need for innovative interventions [Addiction Opinion and Debate]. Pardo B., Taylor J., Caulkins J., Reuter P., Kilmer B., p. 1304-1312. - Addressing fentanyl-related harms: maximizing the efficiency of innovative interventions. May T., Buhociu M., Holloway K., p. 1313-1314. - The same fundamental drivers but differently expressed: what can we learn from comparing the recent experiences with synthetic opioids in the US and Europe? Griffiths P., Mounteney J., Sedefov R., p. 1314-1316. - It is time to recognize that synthetic opioids are not going away. Bohnert A.S.B., Lin L.A., p. 1316-1317. - New synthetic drugs require new policies. Pardo B., Taylor J., Caulkins J., Reuter P., Kilmer B., p. 1317-1318. - The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Simons D., Shahab L., Brown J., Perski O., p. 1319-1368. - Commentary on Simons et al. Public health implications of the suggested association between nicotine, smoking and infection with SARS-CoV-2. Bar-Zeev Y., p. 1369-1370. - Alcohol-related harm in emergency departments: linking to subsequent hospitalizations to quantify under-reporting of presentations. Sims S., Preen D., Pereira G., Fatovich D., Livingston M., O'Donnell M., p. 1371-1380. - Shifts in alcohol consumption during the COVID-19 pandemic: early indications from Australia. Callinan S., Smit K., Mojica-Perez Y., D'Aquino S., Moore D., Kuntsche E., p. 1381-1388. - Adolescent income and binge drinking initiation: prospective evidence from the MyLife study. Brunborg G.S., von Soest T., Burdzovic Andreas J., p. 1389-1398. - Cross-country differences in age trends in alcohol consumption among older adults: a cross-sectional study of individuals aged 50 years and older in 22 countries. Calvo E., Allel K., Staudinger U.M., Castillo-Carniglia A., Medina J.T., Keyes K.M., p. 1399-1412. - Recovery from alcohol problems in the absence of treatment: a qualitative narrative analysis. Mellor R., Lancaster K., Ritter A., p. 1413-1423. - Applying Bayesian cognitive models to decisions to drive after drinking. McCarthy D.M., McCarty K.N., Hatz L.E., Prestigiacomo C.J., Park S., Davis-Stober C.P., p. 1424-1430. - Effect of a 1-year short message service in detoxified alcohol-dependent patients: a multi-center, open-label randomized controlled trial. Lucht M., Quellmalz A., Mende M., Broda A., Schmiedeknecht A., Brosteanu O., et al., p. 1431-1442. - Effect of alcohol label designs with different pictorial representations of alcohol content and health warnings on knowledge and understanding of low-risk drinking guidelines: a randomized controlled trial. Gold N., Egan M., Londakova K., Mottershaw A., Harper H., Burton R., et al., p. 1443-1459. - Risk of overdose-related death for people with a history of incarceration. Gan W.Q., Kinner S.A., Nicholls T.L., Xavier C.G., Urbanoski K., Greiner L., et al., p. 1460-1471. - Does correctional supervision of amphetamine users reduce the risk of re-offending? Weatherburn D., Yeong S., p. 1472-1481. - Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Nielsen S., Sanfilippo P., Belackova V., Day C., Silins E., Lintzeris N., et al., p. 1482-1494. - Age-based preferences for risk communication in the fentanyl era: 'A lot of people keep seeing other people die and that's not enough for them'. Gunn C.M., Maschke A., Harris M., Schoenberger S.F., Sampath S., Walley A.Y., et al., p. 1495-1504. - Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA. Hill L.G., Loera L.J., Evoy K.E., Renfro M.L., Torrez S.B., Zagorski C.M., et al., p. 1505-1511. - Commentary on Hill et al.: Breaking down barriers-increasing access to lifesaving opioid use disorder medications to save lives. Toce M.S., Hadland S.E., p. 1512-1513. - Impact of policy changes on the provision of naloxone by pharmacies in Ontario, Canada: a population-based time-series analysis. Antoniou T., Martins D., Campbell T., Tadrous M., Munro C., Leece P., et al., p. 1514-1520. - Experimenting first with e-cigarettes versus first with cigarettes and transition to daily cigarette use among adolescents: the crucial effect of age at first experiment. Legleye S., Aubin H.-J., Falissard B., Beck F., Spilka S., p. 1521-1531. - Risk of neuropsychiatric and cardiovascular adverse events following treatment with varenicline and nicotine replacement therapy in the UK Clinical Practice Research Datalink: a case-cross-over study. Thomas K.H., Davies N.M., Taylor A.E., Taylor G.M.J., Gunnell D., Martin R.M., et al., p. 1532-1545. - Commentary on Thomas et al.: Are simple solutions to complex problems possible? Bonevski B., Walker N., p. 1546-1547. - Socio-economic distribution of e-cigarette use among recent former regular smokers and current smokers at ages 25-26 in England. Gagné T., Brown J., p. 1548-1557. - Evaluation of the London Smoking Cessation Transformation Programme: a time-series analysis. Jackson S.E., Beard E., West R., Brown J., p. 1558-1568. - The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community. McDonell M.G., Skalisky J., Burduli E., Foote A., Sr., Granbois A., Smoker K., et al., p. 1569-1579. - A cluster randomized controlled trial evaluating the effectiveness of the school-based drug prevention program #Tamojunto2.0. Sanchez Z.M., Valente J.Y., Galvão P.P., Gubert F.A., Melo M.H.S., Caetano S.C., et al., p. 1580-1592. - Carfentanil and the rise and fall of overdose deaths in the United States. Jalal H., Burke D.S., p. 1593-1599. - Changes in alcohol consumption associated with social distancing and self-isolation policies triggered by COVID-19 in South Australia: a wastewater analysis study. Bade R., Simpson B.S., Ghetia M., Nguyen L., White J.M., Gerber C., p. 1600-1605. - Essential tobacco dependence medicines in 137 countries. Benipal S., Budhram D.R., Bilimoria K., Woods H., Wang R., Persaud N., p. 1606-1609. |
| Cote : | Abonnement |
| Lien : | https://onlinelibrary.wiley.com/toc/13600443/2021/116/6 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
B. PARDO ;
J. TAYLOR ;
J. CAULKINS ;
P. REUTER ;
B. KILMER
|
BACKGROUND: Overdose deaths related to illegal drugs in North American markets are now dominated by potent synthetic opioids such as fentanyl, a circumstance foreshadowed by often-overlooked events in Estonia since the turn of the century. Marke[...]
Article : Périodique
S. LEGLEYE ;
H. J. AUBIN ;
B. FALISSARD ;
F. BECK ;
S. SPILKA
|
ENGLISH:
BACKGROUND AND AIMS: Most studies in English-speaking countries have found a positive association between e-cigarette experimentation and subsequent daily tobacco smoking among adolescents. However, this result may not be valid in othe[...]
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Accueil
